Description:
Emtricitabine moderately reduces hepatocyte proliferation independent of effects on mtDNA in HepG2 human hepatoma cells.
- Molecular Weight: 247.25
- Molecular Formula: C8H10FN3O3S
Purity: >98%
Canonical SMILES:
C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F
InChI:
InChI=1S/C8H10FN3O3S/c9-4-1-12(8(14)11-7(4)10)5-3-16-6(2-13)15-5/h1,5-6,13H,2-3H2,(H2,10,11,14)/t5-,6+/m0/s1
InChIKey: XQSPYNMVSIKCOC-NTSWFWBYSA-N
- Boiling Point: 443.3±55.0 °C at 760 mmHg
- Melting Point: 153-155°C
- Solubility: In Vitro: DMSO: 10.8 mg/mL (43.68 mM; Need ultrasonic and warming)In Vivo: 1.Emtricitabine (FTC) is prepare in vehicle (DMSO and 0.9% NaCl)
- Appearance: -
- Storage: Powder: -20°C: 3 years4°C: 2 yearsIn solvent: -80°C: 6 months-20°C: 1 month
Synonyms:
Emtricitabine; Coviracil; Emtriva; Racivir; (-)-FTC; W-201247; W-201248; E1007; 24229-EP2298783A1; 24229-EP2314590A1; AB01275429-01; 3B2-0188;
More details are to be found on supplier website
